EISAI SELECTS MEDIDATA'S CLINICAL DATA STUDIO TO ENHANCE AND MODERNIZE CLINICAL TRIAL EFFICIENCY AND PATIENT EXPERIENCE

AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80%

NEW YORK, July 29 (Bernama-BUSINESS WIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced Eisai Inc. (“Eisai”), the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers to harness its recently announced AI-driven Medidata Clinical Data Studio. Eisai Inc., will leverage this innovative data experience to gain unprecedented control over its clinical data, enable the execution of scalable and complex clinical trials, and enhance patient experience.

“We’ve included Medidata’s Clinical Data Studio in our clinical trial management platform given its ability to break down data silos and seamlessly integrate into our current software stack, while maintaining quality and integrity across all data sources,” said Shobha Dhadda, Ph.D. chief clinical science & operations officer, at Eisai. “Having a suite of technology solutions capable of processing diverse clinical and patient data types provides increased efficiencies without sacrificing quality or needing additional resources.”

Clinical Data Studio is powered by the Medidata Platform, the industry’s only unified platform that centrally manages all data sources, improving data reliability across the entire clinical trial ecosystem. By seamlessly integrating data from both Medidata sources, including Medidata Rave EDC, and non-Medidata sources, such as labs or another electronic data capture system, Clinical Data Studio streamlines the import process and enables automatic validation through configured data transfer agreements. Utilizing AI, it mitigates challenges posed by disparate data systems and offers up to 80 percent faster data review while providing a comprehensive view of patient data that can be concurrently reviewed, visualized, and acted on.

“Through Clinical Data Studio, Eisai is enabling healthcare stakeholders to overcome the complexities of modern clinical trials and foster collaboration on cleaner, more actionable data,” said Janet Butler, executive vice president, global head of sales, Medidata. “By delivering a unified AI-driven data management and analytics experience, we are enabling study teams to identify potential data issues faster and gain a more accurate understanding of the patient.”

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 33,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,200+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com.

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.

About Eisai Inc.

Eisai Inc., a human health care company, is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd. headquartered in Nutley, N.J. Dedicated to oncology and neurology, its U.S. operations include research & development; manufacturing; global supply & logistics; and commercial activities. Learn more: https://us.eisai.com; Follow us on X and LinkedIn. 

http://mrem.bernama.com/viewsm.php?idm=49070

Votiro keeps up APAC momentum with new hiring, industry partnerships

KUALA LUMPUR, July 26 (Bernama) -- Votiro, innovator in Zero Trust Data Detection and Response has announced significant growth and advancements in Asia Pacific (APAC) and Japan with key executive appointments, industry partnerships, and market growth.

The company also shares its plans to advance product functionality within the region in the second half of the year, expanding its Content Disarm and Reconstruction (CDR) engine with a real-time data security pillar via Zero Trust Data Detection & Response (DDR).

John Ong, who has over two decades of experience in the cybersecurity industry at companies including Panorays and AlgoSec, joins Votiro as Regional Vice President of Sales, APAC, Japan, and Middle East, to lead expansion in the large growth market.

With a deep understanding of direct and indirect business models specific to the dynamic APAC market, Ong is well-positioned to drive regional growth and serve existing customers and partners.

“We are committed to helping our APAC, Japan, and Middle East customers and partners accelerate cybersecurity strategies and maintain an always-safe and -compliant posture.

“We look forward to working with John and his team to introduce our new real-time data security solutions and further product functionalities with technology partners,” said Votiro Chief Executive Officer, Ravi Srinivasan in a statement.

In recent months, Votiro has implemented key technology integrations with industry partners including Zscaler ZIA, and Palo Alto Networks Prisma platforms, as well as strengthened existing integrations with partners such as Menlo Security and SumoLogic.

The company’s ability to prevent file-borne threats via its patented CDR technology enables it to explicitly meet stringent Zero Trust security requirements and other compliance regulations within the region.

The upcoming expansion of Votiro’s DDR technology will further provide customers and partners with the ability to maintain compliance with data privacy regulations that continue to define data security in the APAC region.

Votiro will be on-site at the AiSP Cloud Security Summit on Sept 14, as well as GovWare from Oct 15 to 17. The on-site team will demonstrate its threat prevention and data privacy capabilities, and talk about the company’s support for regulatory requirements within the APAC region.

-- BERNAMA

AKWEL: TURNOVER OF €528.8M IN THE FIRST HALF OF 2024

PARIS, France, July 26 (Bernama-GLOBE NEWSWIRE) --

Champfromier, Thursday, July 25, 2024

TURNOVER OF €528.8M IN THE FIRST HALF OF 2024

• Turnover down -2.8% at constant scope and exchange rates
• Net cash position of €115.1M on June 30, 2024

AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and E-powertrain parts, has recorded, over the first half of 2024, a consolidated turnover of €528.8M, down -3.1% compared to the first half of 2023.



⁽¹⁾ At constant scope and exchange rates

Over the first half of the year, AKWEL turnover at constant scope and exchange rates decreased by -2.8%, with a foreign exchange impact of -€2.0M.

The turnover is distributed by geographic production area as follows:

• France: €132.8M (-13.5%)
• Europe (excluding France) and Africa: €157.1M (-1.6%)
• North America: €158.7M (+4.4%)
• Asia and the Middle East (including Türkiye): €78.8M (+0.5%)
• South America: €1.5M (-36.6%)
   

Cooling activity remains the main contributor (+0.4%), followed by Decontamination product lines (-20.5%), whose decline explains the sharper decline in activity in France, Mechanisms (-6.8%), Fuel (-1.2%) and Air (+8.7%)..

After disbursement of the dividend, the company reached a consolidated net cash position of €115.1M on June 30, 2024, excluding lease liabilities, with €30.3M of investments made during the six-month period.

Taking into account the activity recorded in the first half of the year and the outlook to date for global automotive production for the full year of 2024, AKWEL expects its turnover to remain stable for the current financial year.
 

An independent family business, trading on Euronext Paris, AKWEL is a parts and systems manufacturer for the automotive and heavy-vehicle industry, and a specialist in fluid management, mechanisms and structural parts for electric vehicles. The Group achieves this with their first-rate industrial and technological know-how in mastering the application and processing of materials (plastic, rubber, metal) and mechatronic integration. Operating in 20 countries across 5 continents, AKWEL employs 9,600 people worldwide. Euronext Paris — Sub-fund B — ISIN: FR0000053027 — Reuters: AKW.PA — Bloomberg: AKW:FP

Attachment

• 2024-07-25_AKWEL_TO-H1_2024_EN_short

SOURCE : Akwel

KIOXIA RECOGNISED FOR GROUNDBREAKING BICS FLASH 3D FLASH MEMORY TECHNOLOGY

KUALA LUMPUR, July 25 (Bernama) -- Kioxia Corporation, the inventor of NAND flash memory, was honoured by FMS: the Future of Memory and Storage with 2024 Lifetime Achievement Award for 3D NAND flash invention.

This breakthrough technology has become fundamental to a wide range of computing applications, including advanced smartphones, personal computers, solid state drives (SSDs), data centres, artificial intelligence, and industrial.

“Our technology has created a new paradigm in the industry, enabling flash memory to vastly increase storage density per cell, die and package.

“I am excited to see our achievements recognised and look forward to witnessing their continued influence in the years to come," said its vice president and technology executive for Memory Division, Atsushi Inoue in a statement.

The Kioxia engineering team, consisting of Hideaki Aochi, Ryota Katsumata, Masaru Kito, Masaru Kido, and Hiroyasu Tanaka, will accept this prestigious award for its pioneering work in developing and commercialising 3D flash memory.

Kioxia presented the concept of BiCS FLASH 3D flash memory technology at the VLSI Symposium in 2007. After announcing the prototype, Kioxia continued development to optimise the technology for mass production, eventually introducing the world’s first 256 gigabit, 48-layer 3D flash memory in 2015.

With a 3D stacked structure that boosts capacity and performance, BiCS FLASH 3D flash memory has been a transformational force in the storage industry.

The technology has enabled higher density storage solutions while maintaining reliability and efficiency, significantly enhancing the capabilities of data centres, consumer electronics, and mobile devices, setting a new standard for flash memory technology.

By leveraging vertical stacking, Kioxia’s BiCS FLASH technology addressed the limitations of planar NAND flash, paving the way for future developments in memory storage solutions, and reinforcing Kioxia Corporation as an industry leader.

-- BERNAMA

POLICYMAKERS URGED TO EMBRACE SELF-CARE IN ADDRESSING GLOBAL HEALTH ISSUES

KUALA LUMPUR, July 24 (Bernama) -- Policymakers and health leaders worldwide are urged to embrace self-care as an essential component of healthcare, by ensuring it is fully integrated into national health systems and policies, as part of this year’s International Self-Care Day.

The Global Self-Care Federation (GSCF) is urging members and campaigners to rally behind the #SelfCareIs movement, which aims to educate global audiences about the critical link between self-care and healthcare.

This initiative also encourages engagement with local policymakers and healthcare providers to call on them to put in place plans for the urgent integration of self-care into the healthcare delivery continuum.

“Our ‘Self-care is healthcare’ campaign is all about fuelling the movement for self-care to be recognised as an integral part of healthcare. It aims to drive greater awareness and recognition of the potential of self-care to people and policymakers across the world.

“At GSCF, we firmly believe that everyone benefits when there is a greater choice of healthcare options and more accessible entries to care,” said its Director General, Judy Stenmark in a statement.

As health systems worldwide continue to face a range of challenges from increased demand on services, to inequity in access to healthcare, evidence shows that self-care can avert an estimated 3.9 million premature deaths each year, through physical activity alone.

In addition, self-care is able to save billions of dollar each year for global healthcare systems and, therefore, national economies; improve the autonomy and agency of disadvantaged groups, including women and girls, in managing their own health; as well as provide a legitimate tool in the pursuit of universal health coverage. 

First recognised by the World Health Organization (WHO) in 1983, the concept of self-care describes the role of individuals in preventing disease, promoting and maintaining their mental and physical health, and actively participating in their healthcare.

Representing associations and manufacturers in the self-care industry, promoting sustainable and better global health outcomes for all, GSCF is the go-to source of information for the self-care industry.

-- BERNAMA

JAPAN MARITIME DAILY HOLDS THE GLOBAL SHIPPING SEMINAR IN SINGAPORE ON 16 SEPTEMBER 2024

Applications have just opened. Valuable discussions for new fuels will be held among Mr. Mikal Bøe, the Chairman & CEO of CORE POWER, and key global VIP speakers.


TOKYO, July 24 (Bernama-BUSINESS WIRE) -- On Monday, 16 September 2024, the leading maritime newspaper in Japan, Japan Maritime Daily (JMD) will host the global seminar in Singapore, The Future of Shipping with Alternative Fuels, on the theme of 'New Era Fuels for Ships'. Co-organized with the Singapore Exchange (SGX), the seminar will show the future of new fuels through the initiatives of major shipping companies and panel discussions.

The keynote speaker will be Mikal Bøe, Chairman & Chief Executive Officer (CEO) of CORE POWER, who will explain the nuclear energy for net-zero emission shipping.

SGX Group's Director Kenneth Ng will give a presentation titled "Pathways to Decarbonisation: Using Shipping and Transitional Fuel Derivatives."

In addition, a panel discussion moderated by Hirofumi Yamamoto, Executive Officer of The Japan Maritime Daily, will include Mr. Jigo Hayashi, Joint General Manager of Tokyo Century Corporation's Ship Finance Division, and Mr. Cheong Jin Yu, Head of Baltic Exchange Asia, on the challenges of decarbonization, including new fuels. A networking party will be held after the seminar, free of charge.

Date and time: 16 September 2024 (Monday), 1:00 pm - 4:20 pm (seminar).
Networking party after the seminar.
Venue: SGX Auditorium, 2 Shenton Way, #02-02 SGX Centre 1, Singapore
Language: English (A summary will be published in The Japan Maritime Daily later)
Participation fee: Free of charge. Capacity of 150 persons.

[Agenda]
• Opening Remarks: JMD and SGX
• Keynote speech: "Why shipping needs Nuclear energy" by Mr. Mikal Bøe, the Chairman & CEO of CORE POWER
• Speech: "Pathways to Decarbonization: Using Shipping and Transitional Fuel Derivatives." by Kenneth Ng, Director SGX Group.

• Panel discussion
Mr. Jigo Hayashi - Joint General Manager, Tokyo Century Corporation
Mr. Michimasa Noda - Vice President, Corporate Strategy and Sustainability, Ocean Network Express
Mr. Cheong Jin Yu - Head of Baltic Exchange Asia
Mr. Takashi Nakabe - President, Onomichi Dockyard
Mr. Roslan Khasawneh – Principal Heavy Distillates Analyst, Kpler
Hirofumi Yamamoto, Executive Officer of The Japan Maritime Daily (moderator)
Additional speaker or topic to be confirmed

To register, please apply via the registration form
https://bit.ly/JMD_SGX_seminar2024

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20240721114901/en/

Contact

Japan Maritime Daily Co., Ltd.
Mr. Motoki Kagotani
Tel: +81 50-5236-6688
Mail: seminar@jmd.co.jp
 

Source : Japan Maritime Daily Co., Ltd.

HONG KONG’S PICC HK RATED EXCELLENT - AM BEST

KUALA LUMPUR, July 22 (Bernama) -- AM Best has affirmed the financial strength rating of A- (Excellent) and the long-term issuer credit rating of “a-” (Excellent) of The People’s Insurance Company of China (Hong Kong) Limited (PICC HK).

In a statement, the global credit rating agency said these credit ratings (ratings) which have a stable outlook reflected PICC HK’s balance sheet strength, was assessed as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management.

The ratings also reflect the strategic importance of the company to its parent, The People’s Insurance Company (Group) of China Limited (PICC Group), as the sole overseas insurance entity and a key component of PICC Group’s overseas strategies.

PICC HK’s risk-adjusted capitalisation, as measured by Best’s Capital Adequacy Ratio, remained at the strongest level at year-end 2023.

The company’s investment portfolio remains well-diversified, with the majority of its assets allocated to investment-grade bonds, cash and cash equivalents, and preference shares, while the remainder is in listed equities and other investments.

With an increasing proportion of liquid invested assets, PICC HK has maintained a strong liquidity position, and other supporting factors include a strong regulatory solvency position, both under the legacy Hong Kong Insurance Ordinance and Hong Kong’s new risk-based capital regime.

PICC HK’s operating performance remains adequate, in which it returned to profitability last year, with net earnings mainly supported by robust investment income owing to its diversified investment portfolio. In 2023, PICC HK achieved positive underwriting results, driven by its profitable inward business.

The company’s business profile is assessed as limited, whereby its underwriting portfolio is exposed to moderate concentration risk in terms of sourcing premium revenue from its affiliated company, PICC Property and Casualty Company Limited, despite the stable profit margin.

PICC HK established its Macau branch in 2022 to better satisfy insurance demand from Portuguese-speaking countries of the world, as well as to provide one-stop general insurance solutions covering mainland China’s greater bay area, Hong Kong and Macau.

-- BERNAMA